Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Invivyd, Inc. (IVVD)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
19 Jan 2024
Adimab, LLC
10% Owner
Invivyd, Inc.
(IVVD)
21,687,906
-18%
5,000,000
$3.95
$19,750,000.00
BUY
1 Sep 2022
Hering David
Chief Executive Officer, Director, Officer
Adagio Therapeutics, Inc.
(ADGI)
8,000
+100%
8,000
$4.52
$36,160.00
BUY
17 Aug 2022
Elia Marc
Director, See Footnote 5
Adagio Therapeutics, Inc.
(ADGI)
9,248,250
+44%
2,850,000
$4.28
$12,194,680.00
BUY
10 Aug 2021
MITHRIL II LP
10% Owner
Adagio Therapeutics, Inc.
(ADGI)
11,241,580
+21%
1,997,000
$17.00
$33,949,000.00
BUY
10 Aug 2021
Redmile Group, LLC
10% Owner
Adagio Therapeutics, Inc.
(ADGI)
3,390,960
+76%
1,470,000
$17.00
$24,990,000.00
BUY
10 Aug 2021
Royan Ajay
Director, 10% Owner
Adagio Therapeutics, Inc.
(ADGI)
11,241,580
+21%
1,997,000
$17.00
$33,949,000.00
BUY
10 Aug 2021
MCGUIRE TERRANCE
Director
Adagio Therapeutics, Inc.
(ADGI)
3,120,194
+19%
500,000
$17.00
$8,500,000.00
Home